Documents & Downloads

Olorigliflozin

Sodium Glucose Co-transporter Inhibitor

Olorigliflozin is a sodium glucose co-transporter inhibitor that effectively reduces blood glucose levels through the inhibition of glucose reabsorption in the kidneys. This compound exhibits significant anti-hyperglycemic activity, making it a valuable tool for research in diabetes management and metabolic disorders. Its mechanism of action contributes to the therapeutic potential in controlling hyperglycemia in diabetic models.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	2035989-50-3
Applications	Sodium Glucose Co-transporter Inhibitor
Formula	C₂₃H₂₇ClO₇
Molecular Weight	450.91
SMILES	O[C@H]1[C@]2(C3=CC(CC4=CC=C(C=C4)OCC)=C(C=C3)Cl)O[C@@](CO2)([C@H]([C@@H]1O)O)[C@H](O)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.